1. Home
  2. IPHA vs DSP Comparison

IPHA vs DSP Comparison

Compare IPHA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$2.05

Market Cap

165.3M

Sector

Health Care

ML Signal

N/A

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$13.48

Market Cap

279.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
DSP
Founded
1999
1999
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
279.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
IPHA
DSP
Price
$2.05
$13.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$5.75
$17.81
AVG Volume (30 Days)
184.0K
263.5K
Earning Date
03-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.14
EPS
N/A
N/A
Revenue
N/A
$344,201,000.00
Revenue This Year
$180.36
$20.27
Revenue Next Year
N/A
$16.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.00
52 Week Low
$1.18
$8.11
52 Week High
$2.71
$14.80

Technical Indicators

Market Signals
Indicator
IPHA
DSP
Relative Strength Index (RSI) 46.64 59.55
Support Level $1.67 $10.36
Resistance Level $2.29 $14.16
Average True Range (ATR) 0.08 0.57
MACD -0.03 0.08
Stochastic Oscillator 6.67 90.69

Price Performance

Historical Comparison
IPHA
DSP

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

Share on Social Networks: